期刊文献+
共找到7,005篇文章
< 1 2 250 >
每页显示 20 50 100
CHRONIC EFFECTS OF EARLY ANGIOTENSIN-CONVERTING ENZYME INHIBITOR (QUINAPRIL) OR ANGIOTENSIN II RECEPTOR BLOCKADE (LOSARTAN) ON HEMODYNAMICS AND REMODELING IN RATS AFTER EXPERIMENTAL MYOCARDIAL INFARCTION
1
作者 K Hu Gaudron +3 位作者 H-J Anders F Weldemann B Kruse G Ertl 《Chinese Medical Journal》 SCIE CAS CSCD 1995年第3期74-74,共1页
The long-term effects of an angiotensin-converting enzyme (ACE) inhibitor on hemodynamics and remodeling
关键词 ACE QUINAPRIL LOSARTAN ON HEMODYNAMICS AND REMODELING IN RATS AFTER EXPERIMENTAL MYOCARDIAL INFARCTION OR ANGIOTENSIN II RECEPTOR BLOCKADE chronic effectS OF EARLY ANGIOTENSIN-CONVERTING ENZYME INHIBITOR
原文传递
Electroacupuncture pretreatment exhibits antidepressive effects by regulating hippocampal proteomics in rats with chronic restraint stress 被引量:8
2
作者 Zhuo Guo Ya Tu +7 位作者 Tian-wei Guo Yun-chu Wu Xue-qin Yang Lan Sun Xin-jing Yang Wen-yue Zhang Yu Wang Xu-hui Zhang 《Neural Regeneration Research》 SCIE CAS CSCD 2015年第8期1298-1304,共7页
The clinical effect of electroacupuncture on depression is widely recognized. However, the signal transduction pathways and target proteins involved remain unclear. In the present study, rat models of chronic restrain... The clinical effect of electroacupuncture on depression is widely recognized. However, the signal transduction pathways and target proteins involved remain unclear. In the present study, rat models of chronic restraint stress were used to explore the mechanism by which electroacupuncture alleviates depression. Rats were randomly divided into control, model, and electroacupuncture groups. Chronic restraint stress was induced in the model and electroacupuncture groups by restraining rats for 28 days. In the electroacupuncture group, electroacupuncture pretreatment at Baihui(GV20) and Yintang(GV29) acupoints was performed daily(1 m A, 2 Hz, discontinuous wave, 20 minutes) prior to restraint for 28 days. Open field tests and body weight measurements were carried out to evaluate the depressive symptoms at specific time points. On day 28, the crossing number, rearing number, and body weights of the model group were significantly lower than those in the control group. Behavior test results indicated that rat models of depressive-like symptoms were successfully established by chronic restraint stress combined with solitary raising. On day 28, an isobaric tag for a relative and absolute quantitation-based quantitative proteomic approach was performed to identify differentially expressed proteins in hippocampal samples obtained from the model and electroacupuncture groups. The potential function of these differential proteins was predicted through the use of the Cluster of Orthologous Groups of proteins(COG) database. Twenty-seven differential proteins(uncharacteristic proteins expected) were selected from the model and electroacupuncture groups. In addition to unknown protein functions, COG are mainly concentrated in general prediction function, mechanism of signal transduction, amino acid transport and metabolism groups. This suggests that electroacupuncture improved depressive-like symptoms by regulating differential proteins, and most of these related proteins exist in nerve cells. 展开更多
关键词 nerve regeneration traditional Chinese medicine electroacupuncture depression chronic restraint stress i TRAQ differential protein proteomics multi-target effect neural regeneration
暂未订购
Health Effect of Forest Bathing Trip on Elderly Patients with Chronic Obstructive Pulmonary Disease 被引量:18
3
作者 JIA Bing Bing YANG Zhou Xin +6 位作者 MAO Gen Xiang LYU Yuan Dong WEN Xiao Lin XU Wei Hong LYU XIAO Ling CAO Yong Bao WANG Guo Fu 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2016年第3期212-218,共7页
Forest bathing trip is a short, leisurely visit to forest. In this study we determined the health effects of forest bathing trip on elderly patients with chronic obstructive pulmonary disease (COPD). The patients we... Forest bathing trip is a short, leisurely visit to forest. In this study we determined the health effects of forest bathing trip on elderly patients with chronic obstructive pulmonary disease (COPD). The patients were randomly divided into two groups. One group was sent to forest, and the other was sent to an urban area as control. Flow cytometry, ELISA, and profile of mood states (POMS) evaluation were performed. In the forest group, 展开更多
关键词 COPD Health effect of Forest Bathing Trip on Elderly Patients with chronic Obstructive Pulmonary Disease
暂未订购
LONG-TERM EFFECT OF HOMOHARRINGTONINE ON CHRONIC GRANULOCYTIC LEUKEMIA 被引量:1
4
作者 李玉峰 朱家斌 +4 位作者 王春玲 丁帮和 李元媛 宣恒报 钱墨生 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2005年第2期150-153,共4页
Objective: To observe the long-term effect of homoharringtonine (HHT) on chronic granulocytic leukemia (CGL) and its pharmacological mechanism. Methods: 76 patients with newly diagnosed early chronic phase CGL receive... Objective: To observe the long-term effect of homoharringtonine (HHT) on chronic granulocytic leukemia (CGL) and its pharmacological mechanism. Methods: 76 patients with newly diagnosed early chronic phase CGL received treatment of merely 1.5 mg/m2 daily HHT for induction remission and long-term maintenance treatment. The apoptosis rate of bone marrow CD34+ cells induced by HHT was assayed with flow cytometer. Results: 86.8% patients achieved CHR, 13.2% patients PHR and 31.8% patients got cytogenetic response in HHT treatment group, which was longer than 31 (8-54) months in hydroxyurea (HU) group (P<0.05). The effect of apoptosis induction HHT was stronger on CGL-CP patients bone marrow CD34+ cells than on normal person bone marrow CD34+ cells. Conclusion: HHT is a very effective drug for remission induction and long-term maintenance treatment in early chronic phase CGL patients. 展开更多
关键词 HOMOHARRINGTONINE chronic granulocytic leukemia Long-term effect CD34+ cells
暂未订购
Effects of Sub-chronic Intoxication of 1,8-cineole on Blood Biochemical Indexes of Mice 被引量:1
5
作者 Du Yonghua Wang Chuan +5 位作者 Zhou Lijun Zhang Ping Wei Qin Yin Zhongqiong Jiang Qinjiu Jiang Jihong 《Animal Husbandry and Feed Science》 CAS 2015年第3期167-170,173,共5页
[ Objective] Effects of sub-chronic intoxication of 1,8-cineole on body weights, routine blood indexes and biochemical indexes of mice were investigated. [Method] One hundred and sixty mice with body weights of 15 -17... [ Objective] Effects of sub-chronic intoxication of 1,8-cineole on body weights, routine blood indexes and biochemical indexes of mice were investigated. [Method] One hundred and sixty mice with body weights of 15 -17 g were randomly divided into four groups (forty mice per group). Mice were injected to 1, 8 - cineole with doses of 192.45,64. 15 and 21.38 mg/kg body weight ( test groups) and the water solution of tween-80 with a volume fraction of 0.5% ( control group) respectively. Each mouse was administered orally at the dose of 0.2 mL per 10 g body weight once a day consecutively for 90 d. The body weight, routine blood indexes and serum biochemical indexes of mice were determined on the 30^th d, 60^th d, 90^th d and the 30^th d after stopping the administration of 1,8-cineole. [ Result] The effects of 1, 8-cineole on the body weight, routine blood indexes and serum biochemical indexes of mice with the doses of 64.15 and 21.38 mg/kg body weight had no statistically significant difference compared with the control group (P 〉0.05 ). 1, 8-cineole with the dose of 192.45 mg/kg body weight exhibited different influences on routine blood indexes and serum biochemical indexes of mice after the oral administration of 1,8-cineole for 60 d and 90 d, and statistically significant differences in many blood biochemical indexes were observed (P 〈 0.05 ). However, the differences in routine blood indexes and serum biochemical indexes were not statistically significant between the test groups and the control group at the 30'h d after stopping the administration of 1, 8-cineole ( P 〉 0.05). [Condusion] 1,8-cineole had sub-chronic oral toxicity to mice. The no observed adverse effect level (NOAEL) of 1,8-cineolc was 64.15 mg/kg body weight and the lowest observed adverse effect level (LOAEL) of 1,8-cineole was 192.45 mg/kg body weight. Effects of 1, 8-cineole on blood biochemical indexes of mice were in short term and reversible. 展开更多
关键词 1 8-cineole Sub-chronic toxicity Lowest observed adverse effect level No observable adverse effect level
在线阅读 下载PDF
Clinical Effect of Auriculoacupuncture Treatment of Chronic Bronchitis and Its Influence on Immunologic Function
6
《World Journal of Acupuncture-Moxibustion》 1997年第4期33-33,共1页
关键词 Clinical effect of Auriculoacupuncture Treatment of chronic Bronchitis and Its Influence on Immunologic Function
暂未订购
A Comparative Study of Antifatigue Effects of Taurine and Vitamin C on Chronic Fatigue Syndrome
7
作者 Shin-Hee Kim Hyun-Jin Kim +4 位作者 Semi Kim Ju-Seop Kang Young Tae Koo Sang Hun Lee Dong-Hyun Paik 《Pharmacology & Pharmacy》 CAS 2022年第8期300-312,共13页
Vitamin C and taurine (TR) are well known as active components for fatigue recovery. However, the mechanism of the anti-fatigue effects of vitamin C and TR is still unclear. Our study was designed to evaluate the anti... Vitamin C and taurine (TR) are well known as active components for fatigue recovery. However, the mechanism of the anti-fatigue effects of vitamin C and TR is still unclear. Our study was designed to evaluate the anti-fatigue activities of vitamin C and TR in an animal test for fatigue and to compare the activities between vitamin C and TR. Materials and Methods: Vitamin C, TR or their combination were orally administrated to mice once daily for 15 days, and then metabolic activities such as blood glucose, triglyceride (TG), lactate, and lactate dehydrogenase (LDH) as well as antioxidant activities such as malondialdehyde (MDA) and superoxide dismutase (SOD) were determined (evaluated) after forced swimming test (FST). Results: Compared with the control group, C100, C200, and T50 showed a tendency to decrease mobility in FST. Moreover, TG (C100, C200, T200), LDH (C200), lactic acid (C100) and MDA (C50, C100, C200) levels were inhibited by vitamin C and TR. Conclusions: These results suggest that vitamin C and TR have anti-fatigue activities in mice, with vitamin C providing a stronger effect. 展开更多
关键词 Vitamin C TAURINE chronic Fatigue Syndrome Anti-Fatigue effect
暂未订购
The effect and safety of chronic total occlusion etrograded recanalization by epicardial collateral channel
8
作者 ZHOU Yi ZHONG Zhi-an +3 位作者 HUANG Ze-han WU Kai-ze MA Dun-liang ZHANG Bin 《South China Journal of Cardiology》 CAS 2019年第1期37-43,共7页
Background Data on retrograde recanalization of epicardial collateral channels in patients with chronic total occlusion(CTO) undergoing percutaneous coronary intervention(PCI) are limited. Fearing about the complicati... Background Data on retrograde recanalization of epicardial collateral channels in patients with chronic total occlusion(CTO) undergoing percutaneous coronary intervention(PCI) are limited. Fearing about the complications of perforation, few CTO patients have chosen retrograde recanalization of epicardial collateral channels. Methods A retrospective analysis was conducted in this study. We followed up eligible patients who underwent continuous CTO via epicardial CCS from August 2011 to October 2018 in our center, and analyzed the detailed clinical baseline and angiographic data, surgical success rate and hospital complications to determine the efficacy and safety. The Cox model was used to compare major adverse cardiac events(MACE) and related co-variables between CTO patients with epicardial CCS perforation and non-perforated PCI patients. Results The study enrolled 191 patients with epicardial CCs PCI of CTO and the long term follow-up time was 24.03±19.18 months.Successful CCs PCI of CTO was achieved in 161(84.8 %) patients. Procedural collateral perforation occurred in23(12.0%) patients. MACEs occurred in 18 patients(9.4%) at 1-year follow-up. Kaplan-Meier curves showed no significant difference in MACEs between perforating recanalization of CCs PCI of CTO and non-perforating PCI of CTO.( adjusted hazard ratios(HR): 0.467; 95% confidence intervals(CI): 0.13 to 1.69, P=0.245). The multivariate Cox regression analysis identified the Werner score=0/1(HR: 5.80; 95% CI: 1.89 to 17.8; P=0.002) as significant independent predictors of perforation of CCs PCI of CTO. Conclusions The major complication of the procedure is collateral perforation. Recanalization of CTOs through epicardial collateral channel is safe and effective. It may be a available choice for recanalization of complex CTO.[S Chin J Cardiol 2019;20(1):37-43] 展开更多
关键词 EPICARDIAL COLLATERAL CHANNEL chronic total occlusion COLLATERAL PERFORATION SAFETY and effective
原文传递
Observation on the Effect of Health Education in Health Management of Chronic Disease Patients
9
作者 Wen Zhong 《Journal of Biosciences and Medicines》 2024年第2期294-302,共9页
Objective: By the end of 2021, the aging rate of China’s population is 18.9%, and the prevalence rate of chronic diseases in the elderly population is increasing year by year, and chronic diseases have become the mai... Objective: By the end of 2021, the aging rate of China’s population is 18.9%, and the prevalence rate of chronic diseases in the elderly population is increasing year by year, and chronic diseases have become the main causes of death and health threats of Chinese residents. Therefore, how to manage this huge group well is crucial. This paper analyzes the value of health education in the process of health management for patients with chronic diseases. Methods: 102 patients with chronic diseases treated from January 2021 to December 2021 were divided into control group and experimental group by random number table method. The control group was given routine health management while the experimental group was given health education based on the control group, and the implementation effect was analyzed. Results: After management, the scores of chronic disease knowledge in the experimental group were significantly higher than those in the control group, and the dimensions of ESCA were higher than those in the control group, and P < 0.05;Conclusion: The implementation of health education in the process of chronic disease health management is helpful to improve patients’ self-care ability and better control disease progression. 展开更多
关键词 chronic Disease Patients Health Education Health Management Implementation effect
暂未订购
Effectiveness of an Secondary Prevention Program in Chronic Kidney Disease
10
作者 Carlos Enrique Yepes Delgado Yanett Marcela Montoya Jaramillo +4 位作者 Beatriz Elena Orrego Orozco Paulina Bernal Ramírez Luz Denise González José Miguel Abad Echeverri María Patricia Arbeláez Montoya 《Open Journal of Nephrology》 2013年第3期139-147,共9页
Background: There are many programs which focus on late-stage chronic kidney disease (CKD), and it is considered that further evidence needs to be generated regarding the effectiveness of the programs used before rena... Background: There are many programs which focus on late-stage chronic kidney disease (CKD), and it is considered that further evidence needs to be generated regarding the effectiveness of the programs used before renal replacement therapy. Study Design: A cohort study. Settings & Participants: Patients over 15 years of age who had been diagnosed with CKD according to the KDOQI (Kidney Disease Outcomes Quality Initiative) guidelines and who had undergone conventional treatment (CT) or a renal protection program (RPP). These were patients of two Colombian health insurance companies. Predictors: Age, sex, marital status, comorbidities, CKD stage, and clinical indicators. Outcomes: First CKD progression, and need for renal replacement therapy (RRT). Measures: Clinical marker. Results: The RPP is structurally and functionally different from the CT. It offers the interdisciplinary management of patients, a greater number of medical appointments, and patients start to receive treatment at younger ages and at earlier stages of their condition. The clinical markers of the patients following the RPP are within adequate ranges, and their renal function is less impaired, despite the differences in basal conditions. Upon finishing the study, we found that patients who received CT had a higher risk of receiving nephrotoxic drugs and not receiving nephroprotective drugs. The explanatory variables for the first progression were age, stage, history of dyslipidemia, and hemoglobin, potassium, and albumin levels. These variables, together with glycemia levels were also valid for RRT, except for history of dyslipidemia, as it was not significant. Upon adjusting for the explanatory variables, it was found that belonging to the RPP and attending more appointments had a protective effect in the process of controlling renal damage. Limitations: A possible selection bias. Conclusions: Belonging to a structured renal protection program is an effective way to keeping the clinical markers associated with renal impairment within normal ranges. 展开更多
关键词 chronic KIDNEY Disease RENAL Protection PROGRAM effectIVENESS Clinical MARKERS PROGRESSION of RENAL Damage RENAL Replacement PROGRAM
暂未订购
A systematic review of the effectiveness of clinical nurse specialist interventions in patients with chronic obstructive pulmonary disease(COPD) 被引量:2
11
作者 Hua Yin Ling Yang Qiao Ye 《Frontiers of Nursing》 CAS 2018年第2期147-156,共10页
Objective: This review aimed to examine the effectiveness of clinical nurse specialist (CNS) interventions in patients with chronic obstructive pulmonary disease (COPD). COPD significantly affects p... Objective: This review aimed to examine the effectiveness of clinical nurse specialist (CNS) interventions in patients with chronic obstructive pulmonary disease (COPD). COPD significantly affects people's health worldwide. With the development in nursing, CNSs are playing increasingly important roles in different departments. However, the studies on the effectiveness of CNSs in COPD are not as well organized as the studies on the effectiveness of CNSs in bronchiectasis and asthma. Therefore, this review aims to find some updated evidence on the CNS interventions for patients with COPD and on whether these interventions are effective.Methods: A narrative analysis of the data was performed for the eligible studies. Four databases were chosen: CINAHL, MEDLINE, British Nursing Index, and Cochrane Library. Other websites such as the National Institute for Health and Clinical Excellence, National Health Service Evidence, Association of Respiratory Nurse Specialists, and National Association of Clinical Nurse Specialist were searched as well. Two reviewers performed study identification independently, and all the retrieved articles were stored using the EndNote X7 software. The risk of bias in the included studies was assessed using the Cochrane Collaboration's risk of bias tool. Results: A total of nine studies were included in this review. There were five current interventions by CNSs for patients with COPD. These interventions were home nursing support, CNS]s supported discharge, multidisciplinary cooperation programs, nurse-led care programs, and self-care management education. The effectiveness of these five interventions was evaluated individually. There is low- to moderate-quality evidence indicating that home nursing support interventions may have a positive effect on mortality and quality of life. No significant difference in quality of life has been found between the CNS-supported discharge intervention and the usual service. The multidisciplinary cooperation program probably had a positive effect on quality ot life in patients with COPD. Both nurse-led care and self-care management education intervention had a positive effect on mortality of patients with COPD.Conclusions: The findings of this review provide updated evidence on the effectiveness of CNS interventions for patients with COPD. Although nine trials were included and five types of interventions were identified, there is still lack of high-quality evidence. 展开更多
关键词 chronic obstructive pulmonary disease (COPD) clinical nurse specialists (CNSs) effectIVENESS systematic review advanced practice nurse RNS CNS led
暂未订购
Double-Blind, Parallel Group Study to Compare the Clinical Effectiveness of Calcium Dobesilate 500 mg BID vs. Calcium Dobesilate LP 1 g OD, in Patients with Chronic Venous Insufficiency of the Lower Limbs
12
作者 Ramón Téllez Méndez Maria González Yibirin David Rincón Matute 《International Journal of Clinical Medicine》 CAS 2024年第5期211-223,共13页
Background: Chronic venous insufficiency (CVI) describes a condition that affects the venous system of the lower extremities due to venous hypertension (VH. The prevalence is between 5% - 30%. CVI is associated with o... Background: Chronic venous insufficiency (CVI) describes a condition that affects the venous system of the lower extremities due to venous hypertension (VH. The prevalence is between 5% - 30%. CVI is associated with older age, smoking, lower extremity trauma, presence of an arteriovenous shunt, and elevated estrogen levels. All patients should be initially treated with conservative management. Venoactive drugs like calcium dobesilate are useful. Objectives: The primary objective compared the clinical improvement in patients with CVI, grades 0 - 3 of the CEAP classification of chronic venous disease, produced by two formulations of calcium dobesilate: calcium dobesilate LP 1 g OD vs calcium dobesilate 500 mg BID, immediate release. The secondary objective assessed the side effects of both formulations. Method: All patients took one tablet and one capsule at 7 am, and one capsule at 7 pm, for 8 weeks. One group received dobesilate 1 g OD and the other group received dobesilate 500 md BID. They were evaluated after 15, 30 and 60 days of treatment, using the symptom evaluation scale. Results: In both groups, there was a significant decrease in the symptom score after 15 days. Four patients in the Dobesilate OD group: had adverse effects, which did not require suspension of treatment. In the BID dobesilate group, there was one therapeutic failure, and one case of gastric discomfort. Conclusions: Prolonged-release Calcium dobesilate 1 g OD is as effective as calcium dobesilate 500 mg BID for the treatment of patients with chronic venous insufficiency. 展开更多
关键词 chronic Venous Insufficiency (CVI) Calcium Dobesilate CEAP Classification Adverse effects Treatment Adherence
暂未订购
Effect of Postoperative Administration of Saireito for Bilateral Chronic Subdural Hematomas
13
作者 Satoshi Utsuki Hidehiro Oka +5 位作者 Chihiro Kijima Madoka Inukai Katsutoshi Abe Kimitoshi Sato Sachio Suzuki Kiyotaka Fujii 《International Journal of Clinical Medicine》 2011年第3期285-288,共4页
The aim of this retrospective study was to investigate the efficacy of saireito for bilateral chronic subdural hematomas (B-CSDH). Between April 2006 and March 2010, a total of 18 patients undergoing unilateral burr h... The aim of this retrospective study was to investigate the efficacy of saireito for bilateral chronic subdural hematomas (B-CSDH). Between April 2006 and March 2010, a total of 18 patients undergoing unilateral burr hole drainage for B-CSDH took part in a controlled clinical study. Postoperative status of the nonsurgical side was subsequently evaluated, with (n = 10) and without (n = 8) saireito administration. Two in the saireito-treated group patients and four in the control group patients ultimately required contralateral surgical intervention. The remainder, including eight saireito-treated hematomas, resolved without further surgery, generally within eight weeks of the surgical side procedure. However, two of the four resolving control lesions took longer to regress. The hydragogue and anti-inflammatory/steroid-evoking properties ascribed to saireito may facilitate hematoma resolution. After unilateral surgery for B-CSDH, saireito administration may prevent symptomatic deterioration of a contralateral low-density CSDH, preempting subsequent surgery. 展开更多
关键词 BILATERAL chronic SUBDURAL Hematomas CONTRALATERAL HEMATOMA Medical Treatment Saireito Steroid-Like effect
暂未订购
“Crowbar Effect”技术促进球囊跨过高阻力冠状动脉慢性完全性闭塞病变的有效性和安全性研究
14
作者 刘睿方 徐方兴 +2 位作者 刘同库 周玉杰 吴小凡 《中国全科医学》 北大核心 2023年第29期3683-3688,共6页
背景经皮冠状动脉介入治疗(PCI)开通冠状动脉慢性完全性闭塞(CTO)失败的原因之一是球囊不能跨过CTO病变。目的评估“Crowbar Effect”技术促进球囊穿过冠状动脉高阻力CTO病变的有效性和安全性,为开通CTO提供一种可选择的新技术和提高CT... 背景经皮冠状动脉介入治疗(PCI)开通冠状动脉慢性完全性闭塞(CTO)失败的原因之一是球囊不能跨过CTO病变。目的评估“Crowbar Effect”技术促进球囊穿过冠状动脉高阻力CTO病变的有效性和安全性,为开通CTO提供一种可选择的新技术和提高CTO开通的成功率。方法选择2010年1月—2019年1月在首都医科大学附属北京安贞医院和北华大学附属医院应用前向技术治疗冠状动脉CTO病变患者648例,其中导丝通过了病变,而球囊不能跨过的高阻力CTO病变84例(12.96%),对其应用“Crowbar Effect”技术促使小球囊通过CTO病变,完成PCI。观察PCI成功率和主要不良心血管事件(MACE)。结果84例CTO病变的J-score评分为(1.63±0.90)分。在第1条导丝成功穿过CTO病变后,由于使用了“Crowbar Effect”技术,小球囊穿透CTO病变的成功率为91.67%(77/84)。仍有7例(8.33%)失败,其中2例因360°严重钙化病变和5例冠状动脉穿孔而失败。84例患者未发生围术期心源性死亡和非致死性心肌梗死。结论“Crowbar Effect”技术是一种有效且安全的技术,可使小型球囊穿过普通球囊不可穿透的CTO病变。应用这种简单的技术开通CTO有很高的成功率和应用价值。 展开更多
关键词 冠状动脉闭塞 冠状动脉慢性完全性闭塞 撬杠作用 冠状动脉介入治疗 治疗效果 安全性
暂未订购
Acupuncture effects on the hippocampal cholinergic system in a rat model of neuropathic pain 被引量:4
15
作者 Junying Wang Junling Liu Shuping Chen Yonghui Gao Fanying Meng Lina Qiao 《Neural Regeneration Research》 SCIE CAS CSCD 2012年第3期212-218,共7页
The present study observed the effects of repeated electroacupuncture of Zusanli (ST36) and Yanglingquan (GB34) on expression of hippocampal acetylcholinesterase, vesicular acetylcholine transporter, and muscarini... The present study observed the effects of repeated electroacupuncture of Zusanli (ST36) and Yanglingquan (GB34) on expression of hippocampal acetylcholinesterase, vesicular acetylcholine transporter, and muscarinic M1 receptor mRNA in chronic constrictive injury (neuropathic pain) and/or ovariotomy rats. Results demonstrated increased expression of hippocampal acetylcholinesterase, vesicular acetylcholine transporter, and muscarinic M1 receptor mRNA, as well as decreased pain threshold, in a rat model of chronic neuropathic pain after electroacupuncture. The effects of electroacupuncture increased with prolonged time, but the above-mentioned effects decreased in memory-deficient animals. Results indicated that repeated electroacupuncture has a cumulative analgesic effect, which is closely associated with upregulation of acetylcholinesterase and vesicular acetylcholine transporter activity, as well as M1 receptor mRNA expression and memory. 展开更多
关键词 ACETYLCHOLINESTERASE chronic pain cumulative effect electroacupuncture analgesia HIPPOCAMPUS M1R mRNA expression vesicular acetylcholine transporter
在线阅读 下载PDF
多种慢性病对年龄相关性黄斑变性风险的影响及其交互效应研究
16
作者 赵颖颖 苏萍 +9 位作者 陈巧巧 逄锦宏 施婕 王雅倩 李秋春 何蕊言 王玥 陈学禹 于媛媛 迟蔚蔚 《中国全科医学》 北大核心 2026年第2期213-218,共6页
背景年龄相关性黄斑变性(AMD)是全球50岁以上人群视力丧失和损伤的主要原因,预计到2040年将影响2.88亿人。目的探讨多种慢性病与AMD之间的关系,分析不同的慢性病组合与AMD风险的交互效应,评估多种慢性病及其相互作用对AMD发生风险的影... 背景年龄相关性黄斑变性(AMD)是全球50岁以上人群视力丧失和损伤的主要原因,预计到2040年将影响2.88亿人。目的探讨多种慢性病与AMD之间的关系,分析不同的慢性病组合与AMD风险的交互效应,评估多种慢性病及其相互作用对AMD发生风险的影响。方法依托齐鲁全生命周期电子健康研究型数据库(Cheeloo LEAD),纳入数据库中2015—2023年健康档案体检信息、个人基本信息、诊断信息完整的50岁以上人群,按照ICD-10(H35.3)编码筛选AMD组。以年龄、性别作为匹配项进行1∶4匹配,选取不患有AMD的人群为对照组。记录两组研究对象的人口基线特征及慢性病情况。采用多因素Logistic回归模型分析高血压、糖尿病、心脏病等慢性病与AMD的关联,并借助方差膨胀因子(VIF)检验共线性,确保模型稳健性。最后,引入交互项以评估不同慢性病组合对AMD风险的协同效应。结果本研究共纳入16780人,其中AMD组3356人,对照组13424人。多因素Logistic回归分析结果显示,在调整混杂因素后,高血压(OR=2.81,95%CI=2.59~3.04)、心脏病(OR=2.02,95%CI=1.86~2.19)、脑卒中(OR=1.82,95%CI=1.66~1.99)、糖尿病(OR=2.72,95%CI=2.47~2.99)、血脂异常(OR=2.01,95%CI=1.78~2.28)、慢性胃部疾病或消化系统疾病(OR=1.90,95%CI=1.72~2.10)、慢性肝脏疾病(OR=2.29,95%CI=2.04~2.57)、情感及精神方面疾病(OR=2.86,95%CI=2.49~3.29)、与记忆相关疾病(OR=1.86,95%CI=1.52~2.28)均是AMD患病的影响因素(P<0.05)。交互效应分析显示,高血压与糖尿病组合对AMD的预测概率为0.40;糖尿病与血脂异常组合对AMD的预测概率为0.40;慢性肝脏疾病与糖尿病组合对AMD的预测概率为0.45;高血压与心脏病组合对AMD的预测概率为0.30;脑卒中与心脏病组合对AMD的预测概率为0.30;慢性胃部疾病与慢性肝脏疾病组合对AMD的预测概率为0.30;情感及精神方面疾病与记忆相关疾病组合对AMD的预测概率为0.45;高血压与情感及精神方面疾病组合对AMD的预测概率为0.45。结论高血压、糖尿病、慢性肝脏疾病等均与AMD的发生有显著关联,特别是慢性肝脏疾病与糖尿病组合、情感及精神方面疾病与记忆相关疾病组合、高血压和糖尿病慢性病组合对AMD的影响更加明显。 展开更多
关键词 黄斑变性 慢性病 山东省 病例对照研究 影响因素分析 交互效应
暂未订购
Management of chronic prostatitis/chronic pelvic pain syndrome(CP/CPPS):an evidence-based approach
17
作者 杨明根 赵晓昆 +2 位作者 吴志平 吕晨 肖灵 《Journal of Medical Colleges of PLA(China)》 CAS 2007年第6期357-363,共7页
Objective:To evaluate the efficacy and safety of the treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Methods- The randomized controlled trials (RCTs) about the treatment for CP/CPPS all o... Objective:To evaluate the efficacy and safety of the treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Methods- The randomized controlled trials (RCTs) about the treatment for CP/CPPS all over the world were searched. MEDLINE (January 1966 to June 2007), EMBASE (January 1988 to June 2007), and 4 Chinese databases were electronically searched. The studies included in the refer- ences of eligible studies were additionally searched. Two reviewers independently screened the studies for eli- gibility, evaluated the quality and extracted the data from the eligible studies, with confirmation by cross- checking. Divergences of opinion were settled by discussion or consulted by the experts. Meta-analysis was performed by using RevMan 4.2 software. Results: Twelve original studies involving 1 003 participants met inclusion criteria. Compared with placebo, alpha-blockers could improve the symptoms of CP/CPPS obvious- ly with WMD of NIH-CPSI, total score and pain score were -4.10 (95%CI: -6. 92 to -1.28) and -1.68 (95 %CI: -2.54 to -0. 82). Antibiotics could not improve the symptoms obviously with WMD of NIH-CP- SI; total score and pain score were -2.71 (95%CI: -4. 78 to -0. 64) and -0.86 (95%CI: -2.07 to 0.36). Flavoxate could not improve the NIH-CPSI total score obviously, but could relieve the pain, with WMD of NIH-CPSI total score and pain score being -2.96 (95%CI: -5.17 to -0. 74) and --2.31 (95%CI.. -4.05 to 0.03). Prostat could improve the NIH-CPSI total score obviously, but could not relieve the pain, with WMD of NIH-CPSI total score and pain score being --7. 60 (95%CI.. -9. 97 to -5.23) and -2. 02 (95%CI: -4.07 to 0. 04). Conclusion: Drug intervention could improve total symptoms of CP/CPPS in some degree, but no universally effective treatment is available that can prove significant lasting benefit for all the symptoms of CP/CPPS. Future RCT must use an appropriate sample size and optimal duration and fol- low-up of participants. It is important to improve the quality of internal original studies. 展开更多
关键词 chronic prostatitis chronic pelvic pain syndrome effectiveness systematic review META-ANALYSIS
暂未订购
缬沙坦治疗慢性肾脏病合并高血压的meta分析及药物经济学评价 被引量:1
18
作者 刘俏 许清青 +2 位作者 郑绘 易利丹 罗霞 《中国现代应用药学》 北大核心 2025年第1期124-129,共6页
目的基于meta分析研究缬沙坦治疗慢性肾脏病合并高血压的有效性与安全性,以及开展药物经济学研究,为合理用药提供指导,同时为相关医疗卫生决策提供证据。方法计算机检索PubMed、Embase、The Cochrane Library、中国知网、万方、维普等... 目的基于meta分析研究缬沙坦治疗慢性肾脏病合并高血压的有效性与安全性,以及开展药物经济学研究,为合理用药提供指导,同时为相关医疗卫生决策提供证据。方法计算机检索PubMed、Embase、The Cochrane Library、中国知网、万方、维普等数据库关于缬沙坦治疗慢性肾脏病合并高血压的文献资料,对其有效性和安全性进行meta分析,并采用增量成本效果比(incremental cost-effectiveness ratio,ICER)进行经济学评价,同时进行敏感性分析。结果共纳入有效文献8篇,包括1586例患者。Meta分析结果显示,相较于硝苯地平控释片单药,缬沙坦联合硝苯地平控释片能改善SBP、DBP和UAER,减少不良反应,且差异均有统计学意义(P<0.01)。从卫生体系角度出发,以血压值、UAER值和降压有效率为效果指标,药物经济学分析结果显示缬沙坦单药或联合硝苯地平控释片与其他方案比较,ICER<1倍人均可支配收入或效果更佳的同时成本更低。敏感性分析结果与基础分析结果基本一致。结论缬沙坦单药或联合硝苯地平控释片相较于其他药物方案在慢性肾脏病合并高血压治疗中有效性和经济性具有一定优势,且使用缬沙坦联合治疗不良反应发生率降低,安全性更高。但受纳入研究数量和质量限制,上述结论尚需开展更多高质量研究予以验证。 展开更多
关键词 缬沙坦 慢性肾脏病 高血压 效果 经济性
原文传递
Efficacy of intramuscular matrine in the treatment of chronic hepatitis B 被引量:21
19
作者 Yao Long, Xiao-Tian Lin, Kun-Lun Zeng and Lian Zhang Zhanjiang, China Department of Infectious Diseases, Affiliated Hospital of Guangdong Medical College, Zhanjiang 524001, China Haibin Centre Hospital, Zhanjiang 524005, China Centre of Hepatology of Nanfang Hospital, First Military Medical University, Guang- zhou 510515, China 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2004年第1期69-72,共4页
BACKGROUND: Hepatitis B virus (HBV) infection, a glo- bal public health problem, is the leading cause of cirrhosis and hepatocellular carcinoma (HCC) worldwide. There are more than 350 million HBV carriers in the worl... BACKGROUND: Hepatitis B virus (HBV) infection, a glo- bal public health problem, is the leading cause of cirrhosis and hepatocellular carcinoma (HCC) worldwide. There are more than 350 million HBV carriers in the world and up to one million die annually due to hepatitis B associated liv- er disease. So far no optimal treatment is available for pa- tients with chronic hepatitis B. In the paper we investigated the efficacy of intramuscular matrine in the treatment of chronic hepatitis B. METHODS: One hundred and twenty patients with chronic hepatitis B were randomly divided into matrine treatment group (n =60) and control group (n =60). The patients of the matrine group were given intramuscularly with matrine (an alkaloid extracted from a traditional Chinese herb Radix Sophorae Flavescentis by Guangzhou Ming Xing Pharmaceu cal Factory, Guangzhou, China) of 100 mg daily for 90 days in addition to conventional liver-protective drugs in- cluding glucurone, inosine, compound vitamin B and caryophyllin. The control group received conventional liv- er-protective drugs alone. Clinical manifestations and labo- ratory parameters including liver biochemistry and serum hepatitis B virus markers were monitored before and after treatment in the two groups. RESULTS: Significant differences were seen between the two groups in terms of improvement of clinical symptoms and signs, recovery of liver functions, and serum conver- sion from hepatitis Be antigen to HBe antibody and from positive to negative serum HBV DNA (P <0.05-0.01). The result of the matrine group was more marked than that of the control group. Serious side-effects were not observed except mild pain at the site of injection of matrine in a few patients. CONCLUSION: These results indicate that intramuscular matrine may be an economical, efficacious, safe drug for the treatment of chronic hepatitis B. 展开更多
关键词 chronic hepatitis B/therapy matrine/therapeutical effect HBV DNA hepatitis B surface antigen hepatitis Be antigen SEROCONVERSION
暂未订购
Team Effectiveness in Patient Health Management: An Overview of Reviews
20
作者 Amédé Gogovor Bernard Burnand +2 位作者 Sara Ahmed Terrence Montague Isabelle Peytremann-Bridevaux 《International Journal of Clinical Medicine》 2012年第7期614-627,共14页
Background: The desire to improve the quality of health care for an aging population with multiple chronic diseases is fostering a rapid growth in interprofessional team care, supported by health professionals, govern... Background: The desire to improve the quality of health care for an aging population with multiple chronic diseases is fostering a rapid growth in interprofessional team care, supported by health professionals, governments, businesses and public institutions. However, the weight of evidence measuring the impact of team care on patient and health system outcomes has not, heretofore, been clear. To address this deficiency, we evaluated published evidence for the clinical effectiveness of team care within a chronic disease management context in a systematic overview. Methods: A search strategy was built for Medline using medical subject headings and other relevant keywords. After testing for performance, the search strategy was adapted to other databases (Cinhal, Cochrane, Embase, PsychInfo) using their specific descriptors. The searches were limited to reviews published between 1996 and 2011, in English and French languages. The results were analyzed by the number of studies favouring team intervention, based on the direction of effect and statistical significance for all reported outcomes. Results: Sixteen systematic and 7 narrative reviews were included. Diseases most frequently targeted were depression, followed by heart failure, diabetes and mental disorders. Effectiveness outcome measures most commonly used were clinical endpoints, resource utilization (e.g., emergency room visits, hospital admissions), costs, quality of life and medication adherence. Briefly, while improved clinical and resource utilization endpoints were commonly reported as positive outcomes, mixed directional results were often found among costs, medication adherence, mortality and patient satisfaction outcomes. Conclusions: We conclude that, although suggestive of some specific benefits, the overall weight of evidence for team care efficacy remains equivocal. Further studies that examine the causal interactions between multidisciplinary team care and clinical and economic outcomes of disease management are needed to more accurately assess its net program efficacy and population effectiveness. 展开更多
关键词 TEAM CARE effectIVENESS chronic Disease Management chronic CARE Model OVERVIEW of REVIEWS
暂未订购
上一页 1 2 250 下一页 到第
使用帮助 返回顶部